Exogenous surfactant therapy in 2013: what is next? who, when and how should we treat newborn infants in the future?

BACKGROUND: Surfactant therapy is one of the few treatments that have dramatically changed clinical practice in neonatology. In addition to respiratory distress syndrome (RDS), surfactant deficiency is observed in many other clinical situations in term and preterm infants, raising several questions...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Emmanuel, Gascoin, Géraldine, Flamant, Cyril, Merhi, Mona, Tourneux, Pierre, Baud, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851818/
https://www.ncbi.nlm.nih.gov/pubmed/24112693
http://dx.doi.org/10.1186/1471-2431-13-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851818/
https://www.ncbi.nlm.nih.gov/pubmed/24112693
http://dx.doi.org/10.1186/1471-2431-13-165

Ejemplares similares